PHGE BiomX Inc
Price (delayed)
$0.629
Market cap
$15.7M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.47
Enterprise value
$7.47M
BiomX is a clinical-stage biotechnology company developing both natural and engineered phage cocktails designed to target and destroy bacteria that affect the appearance of skin, as well as target bacteria
Highlights
PHGE's EPS has surged by 88% since the previous quarter and by 71% year-on-year
BiomX's net income has surged by 77% QoQ and by 32% YoY
The quick ratio has surged by 51% year-on-year but it has declined by 22% since the previous quarter
The equity fell by 36% QoQ
Key stats
What are the main financial stats of PHGE
Market
Valuations
Earnings
Shares outstanding
24.97M
Market cap
$15.7M
Enterprise value
$7.47M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.47
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$44.52M
Net income
-$17.73M
EBIT
-$16.84M
EBITDA
-$15.04M
Free cash flow
-$36.93M
Per share
Balance sheet
Liquidity
EPS
-$1.47
EPS diluted
-$3.36
Free cash flow per share
-$3.07
Book value per share
$1.33
Revenue per share
$0
TBVPS
$3.6
Total assets
$43.23M
Total liabilities
$19.09M
Debt
$9.58M
Equity
$24.15M
Working capital
$12.25M
Debt to equity
0.4
Current ratio
2.48
Quick ratio
2.15
Net debt/EBITDA
0.55
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-28%
Return on equity
-88.7%
Return on invested capital
-48.7%
Return on capital employed
-48.2%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
PHGE stock price
How has the BiomX stock price performed over time
Intraday
27.59%
1 week
20.92%
1 month
0.75%
1 year
-83.62%
YTD
-13.85%
QTD
13.19%
Financial performance
How have BiomX's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$44.52M
Net income
-$17.73M
Gross margin
N/A
Net margin
N/A
BiomX's net income has surged by 77% QoQ and by 32% YoY
PHGE's operating income has shrunk by 76% YoY and by 34% QoQ
Growth
What is BiomX's growth rate over time
Valuation
What is BiomX stock price valuation
P/E
N/A
P/B
0.47
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
PHGE's EPS has surged by 88% since the previous quarter and by 71% year-on-year
The stock's P/B is 75% below its 5-year quarterly average of 1.5
The equity fell by 36% QoQ
Efficiency
How efficient is BiomX business performance
The ROE has soared by 83% since the previous quarter and by 63% year-on-year
The ROA has soared by 79% from the previous quarter and by 62% YoY
PHGE's return on invested capital has surged by 79% since the previous quarter and by 68% year-on-year
Dividends
What is PHGE's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for PHGE.
Financial health
How did BiomX financials performed over time
The total assets is 127% greater than the total liabilities
The total assets has surged by 73% year-on-year but it has declined by 28% since the previous quarter
BiomX's current ratio has surged by 57% YoY but it has decreased by 22% QoQ
BiomX's debt is 60% less than its equity
The company's debt to equity has shrunk by 92% YoY but it has surged by 54% QoQ
BiomX's debt has decreased by 36% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.